Current Updates on Simultaneous Prevention of COVID-19 and Monkeypox

In 2022, the outbreak of monkeypox (Mpox) and the COVID-19 pandemic overlapped, raising concerns about the possibility that both viral infections might lead to the same heart problems, and questions about whether vaccination against both viruses could also increase cardiac complications caused by myocarditis or pericarditis. Because of these initial concerns, it was recommended that vaccines against both viruses be administered at separate intervals. However, recently, the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP) have relaxed vaccination requirements while still emphasizing targeted precautions for high-risk individuals. This editorial outlines the updated national guidance issued by the CDC and ACIP and compares it with previous recommendations, providing clinicians with insight into how to safely and effectively implement these changes in clinical practice.